Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Petros Grivas(Seattle Cancer Care Alliance), Shuchi Gulati(Comprehensive Blood & Cancer Center), Deborah B. Doroshow(Icahn School of Medicine at Mount Sinai), Ali Raza Khaki(Palo Alto Institute), Dimitrios Farmakiotis(Brown University), Paolo F. Caimi(University Hospitals Seidman Cancer Center), Matthew D. Galsky(Icahn School of Medicine at Mount Sinai), Leslie A. Fecher(University of Pennsylvania), Catherine Curran(Dana-Farber Cancer Institute), Maheen Z. Abidi(University of Colorado Denver), Brian I. Rini(Vanderbilt University Medical Center), Nathaniel Bouganim(McGill University Health Centre), Shirish M. Gadgeel(Chinese University of Hong Kong), Ziad Bakouny(Dana-Farber Cancer Institute), Julie Fu(Stanford University), Becky Dixon(St. Elizabeth Healthcare), Michael A. Thompson(The University of Melbourne), Chih–Yuan Hsu(Vanderbilt University Medical Center), Punita Grover(University of Cincinnati), Angelo Cabal(University of California San Diego), Eric B. Durbin(University of Kentucky), Arielle Elkrief(Centre Hospitalier de l’Université de Montréal), Mehmet Asım Bilen(Emory Healthcare), Corrie Painter, Toni K. Choueiri(Harvard University), Benjamin French(Vanderbilt University Medical Center), Sanjay Mishra(Vanderbilt University Medical Center), Trisha M. Wise‐Draper(University of Cincinnati), Yu Shyr(Vanderbilt University), Solange Peters(University Hospital of Lausanne), Conor Hennessy(Vanderbilt University Medical Center), Donna R. Rivera(National Cancer Institute), Sharad Goyal(George Washington University), Christopher R. Friese(University of Michigan), Babar Bashir(Thomas Jefferson University), Stephanie Berg(Loyola University Medical Center), Tanios Bekaii‐Saab(WinnMed), Aakash Desai(University of Connecticut), Xuanyi Li(Vanderbilt University), David D. Chism(Vanderbilt University Medical Center), Eric Bernicker(Methodist Hospital), Aldo Di Fazio(Tufts Medical Center), David Gill(Intermountain Healthcare), Daniel W. Bowles(University of Colorado Denver), Poorva Bindal(Beth Israel Deaconess Medical Center), Michael Glover(Stanford University), D.B. Flora(St. Elizabeth Healthcare), Rohit Bishnoi(University of Florida), Jennifer Crowell(St. Elizabeth Healthcare), Jared D. Acoba(University of Hawaiʻi at Mānoa)
Cited by 326
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
|The Lancet|2016|4.8k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k